Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.32 USD
Change Today -0.12 / -1.86%
Volume 471.6K
CORT On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph K. Belanoff M.D.

Co-Founder, Chief Executive Officer, President and Director, Corcept Therapeutics Incorporated
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 1 different industries.

See Board Relationships
57$571,250
As of Fiscal Year 2014

Background*

Dr. Joseph K. Belanoff, M.D. is a Co-Founder of Corcept Therapeutics Inc. and has been its Chief Executive Officer since 1999 and has also been its President since January 1, 2014. Dr. Belanoff has been a Director of Corcept Therapeutics Inc. since 1999. Dr. Belanoff serves as a Faculty Member and has held various positions in the Department of Psychiatry and Behavioral Sciences at Stanford University since 1992. From 1997 to 2001, he served as Director of Psychopharmacology ...

Read Full Background

Corporate Headquarters*

149 Commonwealth Drive
Menlo Park, California 94025

United States

Phone: 650-327-3270
Fax: 650-327-3218

Board Members Memberships*

1999-Present
Co-Founder, Chief Executive Officer, President and Director

Education*

BA
Amherst College
MD
Edward S. Harkness Eye Institute

Other Affiliations*

Annual Compensation*

Salary$571,250
Total Annual Compensation$571,250

Stock Options*

Exercisable Options3,100,023
Exercisable Options Value$3,664,584
Unexercisable Options499,977
Unexercisable Options Value$385,416
Total Value of Options$4,050,000
Total Number of Options3,600,000

Total Compensation*

Total Annual Cash Compensation$571,250
Total Short Term Compensation$571,250
Total Calculated Compensation$571,250
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CORT:US $6.32 USD -0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph Jimenez MBAChief Executive Officer
Novartis AG
SFr.6.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CORCEPT THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.